Pacific Institute for Research and Evaluation

Closed portfolio snapshot

According to ClinicalTrials.gov-derived indexes, Pacific Institute for Research and Evaluation sits in the top decile of US sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count).

10 total trials none currently recruiting 9 completed top decile by trial count

Pacific Institute for Research and Evaluation: 10 sponsored US clinical trials, none currently recruiting.

Pacific Institute for Research and Evaluation sponsors 10 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 9 completed. 1 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Drug Abuse, with 1 trials.

Top-decile sponsor footprint

Pacific Institute for Research and Evaluation ranks in the top decile of sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 65/100

9 of 10 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Indexed trials (enrollment closed)

10 total, page 1 of 1

COMPLETED

Improving Native American Elder Access to and Use of Healthcare

NCT03550404
COMPLETED NA

Strategies: Motivational Interviewing/Psychoeducation

NCT03458299
TERMINATED NA

Implementing Restorative Practices for Youth

NCT04067804
COMPLETED NA

Group-based Intervention for Club Patrons

NCT03652688
COMPLETED NA

Family Based Prevention of Alcohol and Risky Sex for Older Teens

NCT03521115
COMPLETED Phase 2

School Support as Structural HIV Prevention for Adolescent Orphans in Kenya

NCT01501864
COMPLETED NA

Evaluation of AlcoholEdu for College

NCT01382979
COMPLETED Phase 4

Vivitrol for Reducing Driving While Impaired Behavior Among Repeat Offenders

NCT00537745
COMPLETED NA

Adolescent Family-Based Alcohol Prevention

NCT00858065
COMPLETED NA

An Effectiveness Trial of Project ALERT

NCT00650585

Phase Distribution

PhaseTrial count
Phase 2 1
Phase 4 1

Therapeutic Areas

Drug Abuse 1
Alcohol Misuse 1
Alcohol Abuse 1

How the Pacific Institute for Research and Evaluation archive is shaped

10 indexed studies, none listed as recruiting (0% open); 9 completed (90%).

Phase mix: 1 late (III/IV) vs 1 early (I/II) (balanced across stages).

Top condition: Drug Abuse (1 trial), 2 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Pacific Institute for Research and Evaluation: archived-pipeline peers nationwide

Peers matched on 10 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Pacific Institute for Research and Evaluation sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%10%20%30%40% Total trials Recruiting share Pacific Institute for Research and EvaluationAdamas PharmaceuticalsAdverum BiotechnologiesAevi Genomic Medicine, LLC, a Cerecor companyAgouron Pharmaceuticals10xBio22nd Century Group23andMe3-C Institute for Social Development
Pacific Institute for Research and Evaluation sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Pacific Institute for Research and Evaluation sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 10 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Pacific Institute for Research and Evaluation page

10 registered trials is a research-attention snapshot, not an endorsement of Pacific Institute for Research and Evaluation or any single study.

  • None of Pacific Institute for Research and Evaluation's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Drug Abuse is the condition Pacific Institute for Research and Evaluation studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Drug Abuse trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Pacific Institute for Research and Evaluation pipeline card: 10 registered trials from official public datasets.Report a data error.